“Call-on Congress” convenes advocates, legislators, health officials to rally for better CRC screening rates and outcomes

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Fight Colorectal Cancer hosted an advocacy event on the National Mall March 16, “Call-on Congress,” to discuss ways to reduce colorectal cancer incidence, improve treatment, and mitigate health disparities. The event included a flag installation on the Mall to honor those affected by CRC. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

In last week’s issue of The Cancer Letter, Jacquelyn Cobb, associate editor, wrote a story about the then-promising legislative package that was passed by the U.S. House of Representatives Jan. 22. At the time, the package was expected to pass in the Senate, provide funding for the federal government through fiscal year 2026, and prevent a government shutdown that looms Jan. 30. 
Longer follow-up results from the investigational phase Ib/II OrigAMI-1 study evaluating amivantamab-vmjw, a bispecific antibody targeting epidermal growth factor receptor and MET, in combination with FOLFOX or FOLFIRI chemotherapy in patients with RAS/BRAF wild-type metastatic colorectal cancer were presented during a poster session at the 2026 American Society of Clinical Oncology Gastrointestinal Cancers Symposium. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login